Reimbursement Committee

 

Purpose

To promote the MedTech industry’s access to funding and reimbursement pathways that enable timely public and private market access.

Objectives

  1. Monitor the implementation of the PL Agreement (except for the management of the SME grant).
  2. Through a collaborative approach and active stakeholder engagement in the development of relevant policy positions, provide:
  • Industry input into the implementation of the Agreement with Government in relation to Prostheses List matters.
  • Industry input into the MBS Review or other changes to the MBS which may impact on market access issues for the MedTech sector.
  • Industry input into public hospital funding issues which may impact on market access issues for the MedTech Sector.
  • Industry input into Commonwealth or State Government initiatives that cover markets beyond those covered by the MBS and Prostheses List arrangements.
  • Report to the Public Affairs Committee following each meeting and engage with the Public Affairs Committee on specific reimbursement issues that require advocacy.

MTAA Secretary: Paul Dale, Director of Policy

Member Name 

Company 

Michael Simmonds (Chair)

Boston Scientific 

Doug Symonds

Medtronic 

Kieran Murphy

Nevro

Laurence Fong

Smith & Nephew 

Sarah Botros

Stryker 

Sheryl Dunlop

Zimmer Biomet 

Georgia Psarros

Baxter Healthcare 

Rebecca Schnabel 

Allergan 

Sarah Griffin 

Medtechnique Consulting 

Rachael Todd

LivaNova

Michael Reynolds

Biotronik

Joel Parrish

Elekta

Sebnem (Shebnem) Erdol

Abbott Medical

Natasha Diasinos

J & J Medical